𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A case of neuroleptic malignant syndrome with a history of general anesthesia

✍ Scribed by T. Sato; T. Hara; M. Takeichi


Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
215 KB
Volume
7
Category
Article
ISSN
0885-6222

No coin nor oath required. For personal study only.

✦ Synopsis


Antidepressant was given to treat a patient with manic-depressive psychosis, depressed type (ICD-9). Following the treatment, she manifested the alteration of the consciousness, autonomic dysfunction, extrapyramidal sign, muscular hypertonicity, hyperthermia, and elevated serum CPK levels. This condition was consistent with the neuroleptic malignant syndrome. Then, along with interruption of medication she was treated with supportive measures and improved progressively.

In her past history, she underwent general anesthesia for operation of mitral valve replacement and at that time she manifested tachycardia, hyperthermia, elevated CPK levels, etc. In the case of patients who manifest a malignant hyperthermia-like state or neuroleptic malignant syndrome-like state, special care is required in selecting anesthetics and psychotropic drugs.


πŸ“œ SIMILAR VOLUMES


A case of tetrabenazine-induced neurolep
✍ Giselle M. Petzinger; Susan B. Bressman πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 404 KB

We report the case of a patient with tardive dystonia and a history of psychiatric illness who showed signs of neuroleptic malignant syndrome (NMS) after chronic treatment with tetrabenazine. The first symptom was a mental status change 'consisting of confusion, disorganized thinking, paranoid delus

Hyperglycemia as a symptom of neurolepti
✍ M. Ishida; K. Otani; S. Kaneko; H. Ishida; S. Kawashima πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 185 KB

A 67-year-old schizophrenic woman developed neuroleptic malignant syndrome (NMS). She had mild diabetes mellitus, which had been controlled with diet therapy only. Upon the onset of NMS, hyperglycemia of up to 490 mg/dl developed. The hyperglycemia persisted during the NMS episode despite insulin tr

Case of neuroleptic malignant-like syndr
✍ Shafeeq S. Ladha; Russell Walker; Holly A. Shill πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 45 KB

## Abstract Neuroleptic malignant‐like syndrome (NMLS) is well described in the treatment of Parkinson's disease. The syndrome is characterized by fever, rigidity, autonomic instability, elevated creatine phosphokinase levels, and altered level of consciousness, which is usually precipitated by lev

Paralytic ileus as a prodromal symptom o
✍ Osamu Tanaka; Koichi Otani; Tsuyoshi Kondo; Sunao Kaneko; Yutaka Fukushima πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 229 KB

## Abstract A schizophrenic patient receiving neuroleptic treatment developed paralytic ileus followed by the neuroleptic malignant syndrome (NMS). The patient had previously experienced two NMS episodes, one of which was also accompanied by paralytic ileus. It is suggested that paralytic ileus can

Neuroleptic malignant syndrome associate
✍ Heidi Lee; James Ryan; George Mullett; Brian A. Lawlor πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 248 KB

Neuroleptic malignant syndrome (NMS) is a rare and sometimes fatal adverse reaction to neuroleptic drugs. Atypical antipsychotic agents, such as risperidone, are thought to be less likely to cause N M S because of their phamacologiical profile. This is a case report of NMS associated with risperidon